Literature DB >> 27966045

Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) multicenter study.

Tomohiko Yamane1,2,3,4, Kenji Ishii5,6, Muneyuki Sakata5,6, Yasuhiko Ikari7,6,8, Tomoyuki Nishio7,6,8, Kazunari Ishii6,9, Takashi Kato6,10, Kengo Ito6,10, Michio Senda7,6.   

Abstract

PURPOSE: The aim of this study was to assess the inter-rater variability of the visual interpretation of 11C-PiB PET images regarding the positivity/negativity of amyloid deposition that were obtained in a multicenter clinical research project, Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI). The results of visual interpretation were also compared with a semi-automatic quantitative analysis using mean cortical standardized uptake value ratio to the cerebellar cortex (mcSUVR).
METHODS: A total of 162 11C-PiB PET scans, including 45 mild Alzheimer's disease, 60 mild cognitive impairment, and 57 normal cognitive control cases that had been acquired as J-ADNI baseline scans were analyzed. Based on visual interpretation by three independent raters followed by consensus read, each case was classified into positive, equivocal, and negative deposition (ternary criteria) and further dichotomized by merging the former two (binary criteria).
RESULTS: Complete agreement of visual interpretation by the three raters was observed for 91.3% of the cases (Cohen κ = 0.88 on average) in ternary criteria and for 92.3% (κ = 0.89) in binary criteria. Cases that were interpreted as visually positive in the consensus read showed significantly higher mcSUVR than those visually negative (2.21 ± 0.37 vs. 1.27 ± 0.09, p < 0.001), and positive or negative decision by visual interpretation was dichotomized by a cut-off value of mcSUVR = 1.5. Significant positive/negative associations were observed between mcSUVR and the number of raters who evaluated as positive (ρ = 0.87, p < 0.0001) and negative (ρ = -0.85, p < 0.0001) interpretation. Cases of disagreement among raters showed generally low mcSUVR.
CONCLUSIONS: Inter-rater agreement was almost perfect in 11C-PiB PET scans. Positive or negative decision by visual interpretation was dichotomized by a cut-off value of mcSUVR = 1.5. As some cases of disagreement among raters tended to show low mcSUVR, referring to quantitative method may facilitate correct diagnosis when evaluating images of low amyloid deposition.

Entities:  

Keywords:  11C-PiB PET; Amyloid imaging; Inter-rater variability; Mean cortical SUVR; Multi-center study

Mesh:

Substances:

Year:  2016        PMID: 27966045     DOI: 10.1007/s00259-016-3591-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

Review 1.  Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.

Authors:  Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.

Authors:  Eric Karran; Marc Mercken; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2011-08-19       Impact factor: 84.694

3.  Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation.

Authors:  T Yamane; Y Ikari; T Nishio; K Ishii; K Ishii; T Kato; K Ito; D H S Silverman; M Senda; T Asada; H Arai; M Sugishita; T Iwatsubo
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-01       Impact factor: 3.825

4.  The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.

Authors:  William E Klunk; Robert A Koeppe; Julie C Price; Tammie L Benzinger; Michael D Devous; William J Jagust; Keith A Johnson; Chester A Mathis; Davneet Minhas; Michael J Pontecorvo; Christopher C Rowe; Daniel M Skovronsky; Mark A Mintun
Journal:  Alzheimers Dement       Date:  2014-10-28       Impact factor: 21.566

5.  Head motion evaluation and correction for PET scans with 18F-FDG in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study.

Authors:  Yasuhiko Ikari; Tomoyuki Nishio; Yoko Makishi; Yukari Miya; Kengo Ito; Robert A Koeppe; Michio Senda
Journal:  Ann Nucl Med       Date:  2012-07-05       Impact factor: 2.668

6.  Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment.

Authors:  N Tolboom; W M van der Flier; M Yaqub; T Koene; R Boellaard; A D Windhorst; P Scheltens; A A Lammertsma; B N M van Berckel
Journal:  Neurology       Date:  2009-12-15       Impact factor: 9.910

7.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

8.  [18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease.

Authors:  Shizuo Hatashita; Hidetomo Yamasaki; Yutaka Suzuki; Kumiko Tanaka; Daichi Wakebe; Hideki Hayakawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-02       Impact factor: 9.236

Review 9.  Beta-amyloid imaging with florbetaben.

Authors:  Osama Sabri; John Seibyl; Christopher Rowe; Henryk Barthel
Journal:  Clin Transl Imaging       Date:  2015-02-12

10.  Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects.

Authors:  Michio Senda; Masahiro Sasaki; Tomohiko Yamane; Keiji Shimizu; Marianne Patt; Henryk Barthel; Bernhard Sattler; Toshiki Nagasawa; Marcus Schultze-Mosgau; Yasuko Aitoku; Ludger Dinkelborg; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-21       Impact factor: 9.236

View more
  29 in total

1.  Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study.

Authors:  Hiroshi Matsuda; Kyoji Okita; Yumiko Motoi; Toshiki Mizuno; Manabu Ikeda; Nobuo Sanjo; Koji Murakami; Taiki Kambe; Toshiki Takayama; Kei Yamada; Takashi Suehiro; Keiko Matsunaga; Takanori Yokota; Ukihide Tateishi; Yoko Shigemoto; Yukio Kimura; Emiko Chiba; Takahiro Kawashima; Yui Tomo; Hisateru Tachimori; Yuichi Kimura; Noriko Sato
Journal:  Ann Nucl Med       Date:  2022-10-04       Impact factor: 2.258

2.  Comparison of Three Automated Approaches for Classification of Amyloid-PET Images.

Authors:  Ying-Hwey Nai; Yee-Hsin Tay; Tomotaka Tanaka; Christopher P Chen; Edward G Robins; Anthonin Reilhac
Journal:  Neuroinformatics       Date:  2022-05-27

3.  Whole-body biodistribution and the influence of body activity on brain kinetic analysis of the 11C-PiB PET scan.

Authors:  Go Akamatsu; Tomoyuki Nishio; Kazuhiko Adachi; Yasuhiko Ikari; Michio Senda
Journal:  Radiol Phys Technol       Date:  2017-09-11

4.  Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study.

Authors:  Ying Wang; Zhihong Shi; Nan Zhang; Li Cai; Yansheng Li; Hailei Yang; Shaobo Yao; Xiling Xing; Yong Ji; Shuo Gao
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

5.  Improved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular disease.

Authors:  Tomotaka Tanaka; Mary C Stephenson; Ying-Hwey Nai; Damian Khor; Francis N Saridin; Saima Hilal; Steven Villaraza; Bibek Gyanwali; Masafumi Ihara; Henri Vrooman; Ashley A Weekes; John J Totman; Edward G Robins; Christopher P Chen; Anthonin Reilhac
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-20       Impact factor: 9.236

6.  Visual interpretation of [18F]Florbetaben PET supported by deep learning-based estimation of amyloid burden.

Authors:  Ji-Young Kim; Dongkyu Oh; Kiyoung Sung; Hongyoon Choi; Jin Chul Paeng; Gi Jeong Cheon; Keon Wook Kang; Dong Young Lee; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-29       Impact factor: 9.236

7.  Improved Accuracy of Amyloid PET Quantification with Adaptive Template-Based Anatomic Standardization.

Authors:  Yuma Tsubaki; Takayoshi Kitamura; Natsumi Shimokawa; Go Akamatsu; Masayuki Sasaki
Journal:  J Nucl Med Technol       Date:  2021-04-05

8.  A 4-Year Follow-Up of Subjects with Visually Equivocal Amyloid Positron Emission Tomography Findings from the Alzheimer's Disease Neuroimaging Initiative Cohort.

Authors:  Minyoung Oh; Minjung Seo; Sun Young Oh; Heeyoung Kim; Byung Wook Choi; Jungsu S Oh; Jae Seung Kim
Journal:  Nucl Med Mol Imaging       Date:  2021-03-04

9.  Feasibility study of a PET-only amyloid quantification method: a comparison with visual interpretation.

Authors:  Natsumi Shimokawa; Go Akamatsu; Miyako Kadosaki; Masayuki Sasaki
Journal:  Ann Nucl Med       Date:  2020-06-13       Impact factor: 2.668

10.  Artificial Intelligence Analysis of Magnetic Particle Imaging for Islet Transplantation in a Mouse Model.

Authors:  Hasaan Hayat; Aixia Sun; Hanaan Hayat; Sihai Liu; Nazanin Talebloo; Cody Pinger; Jack Owen Bishop; Mithil Gudi; Bennett Francis Dwan; Xiaohong Ma; Yanfeng Zhao; Anna Moore; Ping Wang
Journal:  Mol Imaging Biol       Date:  2020-08-24       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.